Literature DB >> 266111

[Induction and maintenance treatment of acute myelogenous leukemia in adults by sequential use of combination chemotherapy (author's transl)].

H H Fülle.   

Abstract

The therapeutic regimens for acute myelogenous leukemia in 2 different periods of time will be described with comparison of their results. A. 28 adults were treated with cytosine arabinoside and 6-thioguanine only. Thereby, 28% complete and 16% partial remissions were achieved. The mean duration of the complete remissions was 23 weeks. The mean survival time of the patients with complete remission amounted to 53 weeks B. 46% complete and 12% partial remissions were obtained in 37 patients treated with cytosine arabinoside and 6-thioguanine doubling the dosage of the above mentioned regimen followed by 3 cycles of TRAP (and COAP). Using a maintenance therapy with modified TRAP, COAP, and POMP cycles the complete remissions lasted 47 weeks at an average. The mean survival time of patients with complete remission was 87 weeks after start of treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266111

Source DB:  PubMed          Journal:  Med Klin        ISSN: 0025-8458


  2 in total

1.  Adjuvant specific immunotherapy in maintenance treatment of adult acute non-lymphocytic leukemia.

Authors:  H Rühl; H H Fülle; K M Koeppen; R Schwerdtfeger
Journal:  Klin Wochenschr       Date:  1981-11-02

2.  [Myelomonocytic leukemia: clinical, cytological, and cytogenetic studies of acute, subacute, and chronic forms (author's transl)].

Authors:  S Mende; H H Fülle; A Knuth; I Weissenfels
Journal:  Blut       Date:  1977-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.